procarbazine has been researched along with Urogenital Neoplasms in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Urogenital Neoplasms: Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kühböck, J | 1 |
1 other study available for procarbazine and Urogenital Neoplasms
| Article | Year |
|---|---|
[Indication and achievements of after-care examinations of urologic tumors. Chemotherapeutic report].
Topics: Aftercare; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; H | 1973 |